Chinese Clinical Practice Guidelines for Perioperative Fluid Therapy in Adults

Title: Chinese Clinical Practice Guidelines for Perioperative Fluid Therapy in Adults
Edition: Updated
Classification: Standard guideline
Field: Treatment
Countries and regions: China
Guidelines users: This guideline is intended for adult patients receiving perioperative fluid therapy.
Evidence classification method: The guideline will use the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) strategy for assessing the quality of evidence and the strength of recommendations. Evidence quality will be categorized as A, B, C, and D, representing high, moderate, low, and very low quality, respectively. High Quality (A): Further research is very unlikely to change our confidence in the estimate of effect. Moderate Quality (B): Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate. Low Quality (C): Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate. Very Low Quality (D): The estimate of effect is very uncertain.
Development unit: Xuanwu Hospital, Capital Medical University; The Third Xiangya Hospital, Central South University
Registration time: 2024-07-03
Registration number: PREPARE-2024CN941
Purpose of the guideline: Perioperative fluid therapy is one of the most critical aspects of surgical procedures, directly impacting patient outcomes. Proper fluid management during the perioperative period can effectively maintain fluid and electrolyte balance, improve circulatory function, reduce postoperative complications, and promote patient recovery. However, current fluid therapy methods and techniques vary across different regions and healthcare institutions, leading to inconsistencies in clinical practice. To provide an efficient fluid therapy plan based on the latest evidence, enhance clinical treatment standards, and standardize fluid therapy procedures in healthcare institutions, we have developed this guideline.